Insulin signal transduction and the IRS proteins

Annual Review of Pharmacology and Toxicology

Volumn 36, Issue , 1996, Pages 615-658

  Myers Jr , Martin G ^a   White, Morris F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cytokines; diabetes; SH2 domains; tyrosine kinases; tyrosine phosphorylation

Indexed keywords

CYTOKINE; GROWTH FACTOR; INSULIN; INSULIN RECEPTOR; PROTEIN; PROTEIN TYROSINE KINASE;

DIABETES MELLITUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029924856     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pa.36.040196.003151     Document Type: Review

References (234)

1. Warram JH, Rich SS, Krolewski AS. 1995. Epidemiology and genetics of diabetes mellitus. In Joslin's Diabetes Mellitus, ed. CR Kahn, GC Weir, pp. 24-56. Philadelphia: Lea & Febiger. 13th ed.
2. Birnbaum MJ. 1993. The insulin-sensitive glucose transporter. Int. Rev. Cytol. 137:239-97
3. Lernmark A. 1995. Insulin-dependent (Type I) diabetes: etiology, pathogenesis and natural history. See Ref. 233, pp. 1423-35
4. Olefsky JM. 1995. Diabetes Mellitus (Type II): etiology and pathogenesis. See Ref. 233, pp. 1436-63
5. Moller DE, O'Rahilly S. 1993. Syndromes of severe insulin resistance: Clinical and pathophysiological features. See Ref. 234, pp. 49-81
6. Flier JS. 1993. An overview of insulin resistance. See Ref. 234, pp. 1-7
7. Taylor SI, Moller DE. 1993. Mutations of the insulin receptor gene. See Ref. 234, pp. 83-121
8. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, et al. 1985. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313:756-61
9. Karlsson FA, Grunfeld C, Kahn CR, Roth J. 1979. Regulation of insulin receptors and insulin responsiveness in 3T3-L1 fatty fibroblasts. Endocrinology 104:1383-92
10. White MF, Kahn CR. 1989. The casacde of autophosphorylation in the β-subunit of the insulin receptor. J. Cell. Biochem. 39:429-41
11. Feener EP, Backer JM, King GL, Wilden PA, Sun XJ, et al. 1993. Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor. J. Biol. Chem. 268: 11256-64
12. White MF, Kahn CR. 1994. The insulin signaling system. J. Biol. Chem. 269:1-5
13. McClain D, Maegawa H, Levy J, Huecksteadt T, Dull TJ, et al. 1988. Properties of a human insulin receptor with a COOH-terminal truncation. I. Insulin binding, autophosphorylation and endocytosis. J. Biol. Chem. 263: 8904-12
14. Maegawa H, McClain DA, Freidenberg G, Olefsky JM, Napier M, et al. 1988. Properties of a human insulin receptor with a COOH-terminal trancation II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects. J. Biol. Chem. 263: 8912-17
15. Chou CK, Dull TJ, Russell DS, Gherzi R, Lebwohl D, et al. 1987. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J. Biol. Chem. 262: 1842-47
16. McClain DA, Maegawa H, Lee J, Dull TJ, Ullrich A, Olefsky JM. 1987. A mutant insulin receptor with defective tyrosine kinase displays no biological activity and does not undergo endocytosis. J. Biol. Chem. 262:14663-71
17. Odawara M, Kadowaki T, Yamamoto R, Shibasaki Y, Tobe K, et al. 1989. Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. Science 245:66-68
18. Moller DE, Yokota A, White MF, Pazianos AG, Flier JS. 1990. A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. J. Biol. Chem. 265:14979-85
19. Rosen OM. 1987. After insulin binds. Science 237:1452-58
20. Shoelson SE, White MF, Kahn CR. 1988. Tryptic activation of the insulin receptor. J. Biol. Chem. 263:4852-60
21. Herrera R, Lebwohl D, Garcia de Herreros A, Kallen RG, Rosen OM. 1988. Synthesis, purification and characterization of the cytoplasmic domain of the human insulin recpetor using a baculovirus expression system. J. Biol. Chem. 263:5560-68
22. Villalba M, Wente SR, Russell DS, Ahn J, Reichelderfer CF, Rosen OM. 1989. Another version of the human insulin receptor kinase domain: expression, purification and characterization. Proc. Natl. Acad. Sci. USA 86:7848-52
23. DeMeyts P. 1995. The structural basis of insulin and insulin-like growth factor-1 receptor binding and negative cooperativity, and its relevance to mitogenic versus metabolic signaling. Diabetologia 37:S135-48
24. Treadway JL, Morrison BD, Soos MA, Siddle K, Olefsky J, et al. 1991. Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Proc. Natl. Acad. Sci. USA 88:214-18
25. Lee J, O'Hare T, Pilch PF, Shoelson SE. 1993 Insulin receptor autophosphorylation occurs asymmetrically. J. Biol. Chem. 268:4092-98
26. Fratalli AL, Treadway JL,. Pessin JE. 1992. Transmembrane signaling by the human insulin receptor kinase. Relationship between intramolecular β subunit trans- and cis-autophosphorylation and substrate kinase activation. J. Biol. Chem. 267:19521-28
27. Shoelson SE, Lee J, Lynch CS, Backer JM, Pilch PF. 1993. BpaB25 insulins. Photoactivatable analogues that quantitatively cross-link, radiolabel, and activate the insulin receptor. J. Biol. Chem. 268:4085-91
28. Cheatham B, Shoelson SE, Yamada K, Goncalves E, Kahn CR. 1993. Substitution of the erB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1. Proc. Natl. Acad. Sci. USA 90:7336-40
29. Schlessinger J. 1988. Signal transduction by allosteric receptor oligomerization. Trends Biochem. Sci. 13:443-47
30. White MF, Shoelson SE, Keutmann H, Kahn CR. 1988. A cascade of tyrosine autophosphorylation in the β-subunit activates the insulin receptor. J. Biol. Chem. 263:2969-80
31. Wilden PA, Backer JM, Kahn CR, Cahill DA, Schroeder GJ, White MF. 1990. Characterization of the insulin receptor with an in vitro mutation at tyrosine 1146: evidence for separate insulin receptor signals regulating cellular metabolism and growth. Proc. Natl. Acad. Sci. USA 87:3358-62
32. Wilden PA, Siddle K, Haring E, Backer JM, White MF, Kahn CR. 1992. The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities. J. Biol. Chem. 267: 13719-27
33. Herrera R, Rosen OM. 1986. Autophosphorylation of the insulin receptor in vitro. Designation of phosphorylation sites and correlation with receptor kinase activation. J. Biol. Chem. 261: 11980-85
34. Rosen OM, Herrera R, Olowe Y, Petruzzelli LM, Cobb MH. 1983. Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc. Natl. Acad. Sci. USA 80:3237-40
35. Shoelson SE, White MF, Kahn CR. 1989. Nonphpsphorylatable substrate analogs selectively block autophosphorylation and activation of the insulin receptor, epidermal growth factor receptor and pp60v-src kinases. J. Biol. Chem. 264:7831-36
36. Rafaeloff R, Maddux BA, Brunetti A, Sbraccia P, Sung CK, et al. 1991. Transmembrane signalling by insulin via an insulin receptor mutated at tyrosines 1158, 1162, and 1163. Biochem. Biophys. Res. Commun. 179:912-18
37. Wilden PA, Kahn CR, Siddle K, White MF. 1992. Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function. J. Biol. Chem. 267:16660-68
38. Hubbard SR, Wei L, Ellis L, Hendrickson WA. 1994. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372:746-54
39. Shoelson SE, Chatterjee S, Chaudhuri M, White MF. 1992. YMXM motifs of IRS-1 define the substrate specificity of the insulin receptor kinase. Proc. Natl. Acad. Sci. USA 89:2027-31
40. Songyang Z, Carraway KL III, Eck MJ, Harrison SC, Feldman RA, et al. 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536-39
41. Koch CA, Anderson DJ, Moran MF, Ellis C, Pawson T. 1991. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252:668-74
42. Myers MG Jr, Sun XJ, Cheatham B, Jachna BR, Glasheen EM, et al. 1993. IRS-1 is a common element in insulin and insulin-like growth factor-1 signaling to the phosphatidylinositol 3′-kinase. Endocrinology 132:1421-30
43. White MF, Maron R, Kahn CR. 1985. Insulin rapidly stimulates tyrosine phosphorylation of a Mr 185,000 protein in intact cells. Nature 318:183-86
44. White MF, Stegmann EW, Dull TJ, Ullrich A, Kahn CR. 1987. Characterization of an endogenous substrate of the insulin receptor in cultured cells. J. Biol. Chem. 262:9769-77
45. Perrotti N, Accili D, Marcus Samuels B, Rees Jones RW, Taylor SI. 1987. Insulin stimulates phosphorylation of a 120-kDa glycoprotein substrate (pp120) for the receptor-associated protein kinase in intact H-35 hepatoma cells. Proc. Natl. Acad. Sci. USA 84:3137-40
46. Margolis RN, Schell MJ, Taylor SI, Hubbard AL. 1990. Hepatocyte plasma membrane ecto-ATPase (pp120/HA4) is a substrate for tyrosine kinase activity of the insulin receptor. Biochem. Biophys. Res. Commun. 166:562-66
47. Najjar SM, Accili D, Philippe N, Jernberg J, Margolis R, Taylor SI. 1993. pp120/ecto-ATPase, an endogenous substrate of the insulin receptor tyrosine kinase, is expressed as two variably spliced isoforms. J. Biol. Chem. 268: 1201-6
48. Lavan BE, Lienhard GE. 1993. The insulin-elicited 60-kDa phosphotyrosine protein in rat adipocytes is associated with phosphatidylinositol 3-kinase. J. Biol. Chem. 268:5921-28
49. Sung CK, Sanchez-Margalet V, Goldfine ID. 1994. Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor, p62, and GTPase-activating protein. J. Biol. Chem. 269:12503-7
50. Bernier M, Laird DM, Lane MD. 1988. Effect of vanadate on the cellular accumulation of pp15, an apparent product of insulin receptor tyrosine kinase action. J. Biol. Chem. 263:13626-34
51. Hresko RC, Bernier M, Hoffman RD, Flores Riveros JR, Liao K, et al. 1988. Identification of phosphorylated 422(aP2) protein as pp15, the 15-kilodalton target of the insulin receptor tyrosine kinase in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 85:8835-39
52. Uddin S, Katzav S, White MF, Platanias LC. 1995. Insulin-dependent tyrosine phosphorylation of the vav proto-oncogene product in cells of hematopoietic origin. J. Biol. Chem. 270:7712-16
53. Gulbins E, Coggeshall KM, Baier G, Katzav S, Burn P, Altman A. 1993. Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation [see comments]. Science 260:822-25
54. Hu P, Margolis B, Schlessinger J. 1993. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling. BioEssays 15: 179-83
55. Pellici G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, et al. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104
56. Skolnik EY, Lee CH, Batzer A, Vicentini LM, Zhou M, et al. 1993. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS-1 and Shc: implications for insulin control of ras signalling. EMBO J. 12:1929-36
57. Schlessinger J. 1994. SH2/SH3 signaling proteins. Curr. Opin. Genet. Dev. 4:25-30
58. Rothenberg PL, Lane WS, Karasik A, Backer J, White M, Kahn CR. 1991. Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase. J. Biol. Chem. 266:8302-11
59. Sun XJ, Rothenberg P, Kahn CR. Backer JM, Araki E, et al. 1991. The structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77
60. Sun XJ, Miralpeix M, Myers MG Jr, Glasheen EM, Backer JM, et al. 1992. The expression and function of IRS-1 in insulin signal transmission. J. Biol. Chem. 267:22662-72
61. Nishiyama M, Wands JR. 1992. Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 183:280-85
62. Keller SR, Kitagawa K, Aebersold RH, Lienhard GE, Garner CW. 1991. Isolation and characterization of the 160,000-Dalton phosphotyrosyl protein, a putative participant in insulin signaling. J. Biol. Chem. 266:12817-20
63. Keller SR, Aebersold RH, Garner CW, Lienhard GE. 1993. The insulin-elicited 160 kDa phosphotyrosine protein in mouse adipocytes is an insulin receptor substrate 1: identification by cloning. Biochim. Biophys. Acta 1172:323-26
64. Liu XJ, Sorisky A, Zhu L, Pawson A. 1995. Molecular cloning of an amphibian IRS-1-like cDNA and involvement of phosphatidylinositol 3-kinase in insulin-induced Xenopus oocyte maturation. Mol. Cell. Biol. 15:3563-70
65. Miralpeix M, Sun XJ, Backer JM, Myers MG Jr, Araki E, White MF. 1992. Insulin stimulates tyrosine phosphorylation of multiple high molecular weight substrates in FAO hepatoma cells. Biochemistry 31:9031-39
66. Wang LM, Myers MG Jr, Sun XJ, Aaronson SA, White MF, Pierce JH. 1993. IRS-1: essential for insulin and IL-4-stimulated mitogenesis in hematopoietic cells. Science 261:1591-94
67. Wang LM, Keegan AD, Li WQ, Lienhard GE, Pacini S, et al. 1993. Common elements in IL4 and insulin signaling pathways in factor dependent hematopoietic cells. Proc. Natl. Acad. Sci. USA 90:4032-36
68. Sun XJ, Wang LM, Zhang Y, Yenush LP, Myers MG Jr, et al. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature. 377:173-77
69. Musacchio A, Gibson T, Rice P, Thompson J, Saraste M. 1993. The PH domain: a common piece in the structural patchwork of signaling proteins. Trends Biochem. Sci. 18:343-48
70. Hall A. 1994. A biochemical function for ras - at last. Science 264:1413-14
71. Gustafson TA, He W, Craparo A, Schaub CD, O'Neill TJ. 1995. Phosphotyrosine-dependent interaction of Shc and IRS-1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 15:2500-8
72. Kavanaugh WM, Williams LT. 1994. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266:1862-65
73. Bork P, Margolis B. 1995. A phosphotyrosine interaction domain. Cell 80: 693-94
74. Batzer AG, Blaikie P, Nelson K, Schlessinger J, Margolis B. 1995. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol. Cell. Biol. 15:4403-9
75. van der Geer P, Pawson T. 1995. The PTB domain: a new protein module implicated in signal transduction. Trends Biochem. Sci. 20:277-80
76. Keegan AD, Nelms K, White M, Wang LM, Pierce JH, Paul WE. 1994. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76:811-20
77. Sun XJ, Crimmins DL, Myers MG Jr, Miralpeix M, White MF. 1993. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell. Biol. 13:7418-28
78. Myers MG Jr, Wang LM, Sun XJ, Zhang YT, Yenush L, et al. 1994. The role of IRS-1/GRB2 complexes in insulin signaling. Mol. Cell. Biol. 14:3577-87
79. Sugimoto S, Wandless TJ, Shoelson SE, Neel BG, Walsh CT. 1994. Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. J. Biol. Chem. 269:13614-22
80. Pluskey S, Wandless TJ, Walsh CT, Shoelson SE. 1995. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J. Biol. Chem 270:2897-900
81. Smith LK, Bradshaw M, Croall DE, Garner CW. 1993. The insulin receptor substrate (IRS-1) is a PEST protein that is susceptible to calpain degradation in vitro. Biochem. Biophys. Res. Commun. 196:767-72
82. Tranisijevik M, Myers MG Jr, Thomas RS, Crimmons D, White MF, Sacks D. 1993. Phosphorylation of the insulin receptor substrate IRS-1 by casein kinase II. J. Biol. Chem. 268:18157-66
83. Lam K, Carpenter CL, Ruderman NB, Friel JC, Kelly KL. 1994. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1 J. Biol. Chem. 269:20648-52
84. Hanks SK, Quinn AM, Hunter T. 1990. The protein kinase family: conserved features and deduced phylogeny of the catalytic domain. Science 241:42-52
85. Myers MG Jr, Sun XJ, White MF. 1994. The IRS-1 signaling system. Trends Biochem. Sci. 19:289-94
86. Cohen GB, Ren R, Baltimore D. 1995. Modular binding domains in signal transduction proteins. Cell 80:237-48
87. Feller SM, Ren R. Hanafusa H, Baltimore D. 1994. SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. Trends Biochem. Sci. 19:453-58
88. Argetsinger LS, Hsu GW, Myers MG Jr, Billestrup N, White MF, Carter-Su C. 1995. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 270:14685-92
89. Souza SC, Frick GP, Yip R, Lobo RB, Tai L-R, Goodman HM. 1994. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 269:30085-88
90. Ridderstale M, Degerman E, Tornqvist H. 1995. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J. Biol. Chem. 27&3471-74
91. Uddin S, Yenush LP, Sun XJ, Sweet ME, White MF, Platanias LC. 1995. Interferon-alpha engages IRS-signaling proteins to regulate the phosphatidylinositol 3-kinase. J. Biol. Chem. 270: 15938-41
92. White MF, Livingston JN, Backer JM, Lauris V, Dull TJ, et al. 1988. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission bul does not affect its tyrosine kinase activity. Cell 54:641-49
93. Backer JM, Kahn CR, Cahill DA, Ullrich A, White MF. 1990. Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamembrane region of the insulin receptor α-subuint. J. Biol. Chem. 265: 16450-54
94. Backer JM, Schroeder GG, Cahill DA, Ullrich A, Siddle K, White MF. 1991. The cytoplasmic juxtamembrane region of the insulin receptor: a critical role in ATP binding, endogenous substrate phosphorylauon, and insulin-stimulated bioeffects in CHO cells. Biochemistry 300:6366-72
95. O'Neill TJ, Craparo A, Gustafson TA. 1994. Characterization of an interaction between insulin receptor substrate-1 and the insulin receptor by using the two-hybrid system. Mol. Cell. Biol. 14:6433-42
96. Craparo A, O'Neill TJ, Gustafson TA. 1995. Non-SH2 domains within the insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor 1 receptor. J. Biol. Chem. 270:15639-43
97. Myers MG Jr, Grammer TC, Brooks J, Glasheen EM, Wang LM, et al. 1995. The pleckstrin homology domain in IRS-1 sensitizes insulin signaling. J. Biol. Chem. 270:11715-18
98. Kavanaugh WM, Turck CW, Williams LT. 1995. PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science 268:1177-79
99. Roth D, Morgan A, Burgoyne RJD. 1993. Identification of a key domain in annexin and 14-3-3 proteins that stimulate calcium-dependent exocytosis in permeabilized adrenal chromaffin cells. FEBS Lett. 320:207-10
100. Blaikie P, Immanuel D, Wu J, Li N, Yajnik V, Margolis B. 1994. A region in she distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J. Biol. Chem. 269: 32031-34
101. Ferguson KM, Lemmon MA, Schless-inger J, Sigler PB. 1994. Crystal structure at 2.2 Å resolution of the pleckstrin homology domain from human dynamin. Cell 79:199-2 09
102. Thomas JD, Sideras P, Smith CIE, Vorechovsky I, Chapman V, Paul WE. 1995. Colocalization of X-linked agammagiobulinemia and X-linked immunodeficiency genes. Science 261: 355-58
103. Rawlings DJ, Saffran DC, Tsukada S, et al. 1993. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358-61
104. Harlan JE, Hajduk PJ, Yoon HS, Fesik SW. 1994. Pleckstrin homology domains bind to phosphatidylinositol 4,5-bisphosphate. Nature 371:168-70
105. Pitcher JA, Touhara K, Payne ES, Lefkowitz RJ. 1995. Pleckstrin homology domain-mediated membrane assocaition and activation of the beta-adrenergic receptor kinase requires coordinate interaction with G-beta/gamma sub units and lipid. J. Biol. Chem. 270: 11707-10
106. Kublaoui B, Lee J, Pilch PF. 1995. Dynamics of signaling during insulin-stimulated endocytosis of its receptor in adipocytes. J. Biol. Chem. 270:59-65
107. Touhara K, Inglese J, Pitcher JA, Shaw G, Lefkowitz RJ. 1994. Binding of G protein beta-gamma-subunits to pleckstrin homology domains. J. Biol. Chem. 14:10217-20
108. Hawes BE, Luttrell LM, Exum ST, Lefkowitz RJ. 1994. Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. J. Biol. Chem. 269:15776-85
109. i-coupled receptor signaling. J. Biol. Chem. 270:12984-89
110. Inglese J, Koch WJ, Touhara K, Lefkowitz RJ. 1995. G-beta-gamma interactions with PH domains and Ras-MAPK signaling pathways. Trends Biochem. Sci. 20:151-56
111. Waksman G, Kominos D, Robertson SC, Pant N, Baltimore D, et al. 1992. Crystal structrue of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358:646-53
112. Booker GW, Breeze AL, Downing AK, Panayotou G, Gout I, et al. 1992. Structure of an SH2 domain of the p85α subunit of phosphatidylinositol-3 OH-kinase. Nature 358:684-87
113. Waksman G, Shoelson SE, Pant N, Cowburn D. Kuriyan J. 1993. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures, of the complexed and peptide-free forms. Cell 72:779-90
114. Lee CH, Kominos D, Jacques S, Margolis B, Schlessinger J, et al. 1994. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the SYP tyrosine phosphatase. Structure 2:423-38
115. Mayer BJ, Jackson PK, Van Etten RA, Baltimore D. 1992. Point mutations in the ab1 SH2 domain coordinately impair phosphotyrosine binding in vitro and trandforming activity in vivo. Mol. Cell. Biol. 12:609-18
116. Escobedo JA, Kaplan DR, Kavanaugh WM, Turck CW, Williams LT. 1991. A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Mol. Cell. Biol. 11:1125-32
117. Fantl WJ, Escobedo JA, Martin GA, et al. 1992. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signalling pathways. Cell 69:413-23
118. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Roberts T, et al. 1993. SH2 domains recognized specific phosphopeptide sequences. Cell 72:767-78
119. Marengere LEM, Songyang Z, Gish GD, Schaller MD, Parsons JT, et al. 1994. SH2 domain specificity and activity modified by a single residue. Nature 369:502-5
120. Ponzetto C, Bardelli A, Maina F, Longati P, Panayotou G, et al. 1993. Mol. Cell. Biol. A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor. 13:4600-8
121. Nishimura R, Li W, Kashishian A, Mondino A, Shou M, et al. 1993. Mol. Cell. Biol. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor. 13:6889-96
122. Ponzetto C, Bardelli A. Zhen Z, Maina F, Zonca PD, et al. 1994. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77:261-71
123. Soler C, Beguino L, Carpenter G. 1994. Individual epidermal growth factor receptor autophosphorylation sites do not stringently define association motifs for several SH2-containing proteins. J. Biol. Chem. 269:12320-24
124. Backer JM, Myers MG Jr, Shoelson SE, Chin DJ, Sun X, et al. 1992. The phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11:3469-79
125. Myers MG Jr, Backer JM, Sun XJ, Shoelson SE, Hu P, et al. 1992. IRS-1 activates the phosphatidylinositol 3′-kinase by associating with the src homolog y 2 domains of p85. Proc. Natl. Acad. Sci. USA 89:10350-54
126. Kapeller R, Cantley LC. 1994. Phosphatidylinositol 3-kinase. BioEssays 16: 565-76
127. PIK reveals a new regulatory subunit for the phosphatidylinositol-3 kinase. Mol. Cell. Biol. 15: 4453-65
128. c-src complexes and PI3-kinase. Cell 65:91-104
129. Hiles ID, Otsu M, Volina S, Fry MJ. Gout I, et al. 1992. Phosphatidylinositol 3-kinase: structure and expression of the 110 kDa catalytic subunit. Cell 70:419-29
130. Hu P, Mondino A, Skolnik EY, Schlessinger J. 1993. Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85. Mol. Cell. Biol. 13:7677-88
131. Myers MG Jr, White MF. 1993. The new elements in insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 42:643-50
132. Dhand R, Hara K, Hiles I, Bax B, Gout I, et al. 1994. PI3-kinase: structural and functional analysis of intersubunit interactions. EMBO J. 13:511-21
133. Hu P, Schlessinger J. 1994. Direct association of p110-beta phosphatidylinositol 3-kinase with p85 is mediated by an n-terminal fragment of p110-beta. Mol. Cell. Biol. 14:2577-83
134. Deleted in proof
135. Holt KH, Olson L, Moye Rowley WS, Pessin JE. 1994. Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p 110 and p85 sub units. Mol. Cell. Biol. 14:42-49
136. Reif K, Gout I, Waterfield MD, Cantrell DA. 1993. Divergent regulation of phosphatidylinositol 3-kinase P85αa and P85β isoforms upon T cell activation. J. Biol. Chem. 268:10780-88
137. Baltensperger K, Kozma LM, Jaspers SR, Czech MP. 1994. Regulation by insulin of phosphatidylinositol 3′-kinase bound to α- and β-Isoforms of p85 regulatory subunit. J. Biol. Chem. 269: 28937-46
138. Vesterguard H, Anderson PH, Bak JF, Pederson O. 1991. Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes 40:1740-45
139. Kelly KL, Ruderman NB. 1993. Insulin-stimulated phosphatidylinositol 3-kinase: association with a 185-kDa tyrosine-phosphorylated protein (IRS-1 ) and localization in a low density membrane vesicle. J. Biol. Chem. 268:4391-98
140. s6k signaling during insulin, IGF-1 and IL-4 stimulation J. Biol. Chem. 269: 28783-89
141. Backer JM, Myers MG Jr, Sun XJ, Chin DJ. Shoelson SE, et al. 1993. Association of IRS-I with the insulin receptor and the phosphatidylinositol 3′-kinase. Formation of binary and ternary signaling complexes in intact cells. J. Biol. Chem. 268:8204-12
142. Van Horn DJ, Myers MG Jr, Backer JM. 1994. Direct activation of the phospbatidylinositol 3′-kinase by the insulin receptor. J. Biochem. 269:29-32
143. Rordorf-Nikolic T, Van Horn DJ, Chen D, White MF, Backer JM. 1995. Regulation of phosphatidylinositol 3-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85 kDa regulatory subunit. J. Biol. Chem. 270:3662-66
144. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, et al. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370: 527-32
145. Hu Q, Klippel A, Muslin AJ, Fand WJ. Williams LT. 1995. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268:100
146. Wood KW, Sarnecki C, Roberts TM, Blenis J. 1992. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68: 1041-50
147. Chung J, Grammer TC, Lemon KP, Kazlauskas A, Blenis J. 1994. PDGF-and insulin-dependent pp70S6k activation mediated by phosphatidylinositol3-OH kinase. Nature 370:71-75
148. Hara K, Yonezawa K, Sakaue H, Ando A, Kotani K, et al. 1994. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for ras activation in CHO cells. Proc. Natl. Acad. Sci. USA 91:7415-19
149. Sakaue H, Hara K, Noguchi T, Matozaki T. Kotani K, et al. 1995. Ras-independent and wortmannin-sensitive activation of glycogen synthase by insulin in Chinese Hamster Ovary Cells. J. Biol. Chem. 270:11304-9
150. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. 1994. Phosphatidylinositol 3-kinase activation is requried for insulin stimulation of pp70 S6 kinase, DNA synthesis and glucose tranporter translocation. Mol. Cell. Biol. 14:4902-11
151. Stoyanov S, Volinia S, Hanck T, Rubio I, Loubtchenkov M, et al. 1995. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269:690-93
152. Stephens L, Smrcka A, Cooke FT, Jackson TR, Sternweis PC, Hawkins PT. 1994. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein β-gamma subunits. Cell 77:83-93
153. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, et al. 1995. A single ataxia telangectasia gene with a product similar to PI 3-kinase. Science 268: 1749-53
154. Schu PV, Kaoru T, Fry MJ, Stack JH, Waterfield MD, Emr SD. 1993. Phosphatidylinositol 3-kinase encoded by yeast VOS34 gene is essential for protein sorting. Science 26:88-91
155. Stack JH, Herman PK, Schu PV, Emr SD. 1993. A membrane-associated complex containing the Vps15 protein kinase and the Vps34 PI3-kinase is essential for protein sorting to the yeast lysosome-like vacuole. EMBO J. 12: 2195-204
156. Volinia S, Dhand R, Vanhaesebroeck B, MacDougall LK, Stein R, et al. 1995. A human phosphatidylinositol 3-kinase complex related to the yeast ps34p-Vps15p protein sorting system. EMBO J. 14:3339-48
157. 1 progression. Cell 73:585-96
158. Chiu MI, Katz H, Berlin V. 1994. RAPT 1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proc. Natl. Acad. Sci. USA 91:12574-78
159. Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH. 1994. RAFTI1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78:35-43
160. Cafferkey R, Young PR, McLaughlin MM, Bergsma DJ, Koltin Y, et al. 1993. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol. Cell. Biol. 13:6012-22
161. 1-arresting rapamycin-receptor complex. Nature 369:756-58
162. Joly M, Kazlauskas A, Corvera S. 1995. Phosphatidylinositol 3-kinase activity is required at a postendocytic step in platelet-derived growth factor receptor trafficking. J. Biol. Chem. 270:13225-30
163. Joly M, Kazlauskas A, Fay FS, Corvera S. 1994. Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science 263:684-87
164. Whitman M, Downes CP, Keeler M, Keller T, Cantley L. 1988. Type I phosphatidylinositol kinase makes a novel mositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332:644-46
165. Nakanishi H, Brewer KA, Exton JH. 1993. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 268: 13-16
166. 3. J. Biol. Chem. 269:32358-67
167. Felber JD, Haesler E, Jequier E. 1993. Metabolic origin of insulin resistance in obesity with and without Type II diabetes mellitus. Diabetologia 36:1221-29
168. Carpenter CL, Auger KR, Duckworth BC, Hou WM, Schaffhausen B, Cantley LC. 1993. A tightly associated serine/ threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol. Cell. Biol. 13:1657-65
169. Dhand R, Hiles I, Panayotou G, Roche S, Fry MJ, et al. 1994. PI-3-kinase is a dual specificity enzyme - autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 13:522-33
170. Weng Q-P, Andrabi K, Koxlowski MT, Grove JR, Avruch J. 1995. Multiple independent inputs are required for activation of the p70 S6 kinase. Mol. Cell. Biol. 15:2333-40
171. Valius M, Kazlauskas A. 1993. Phospholipase C-gammal and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73:321-34
172. Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D. 1993. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363:83-85
173. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, et al. 1993. Guanine-nucleotide-releasing factor mSos1 binds to Grb2 and links receptor tyrosine kinases to ras signalling. Nature 363:85-88
174. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. 1993. Association of Sos ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363:45-51
175. Roberts TM. 1992. A signal chain of events. Nature 360:534-35
176. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, et al. 1992. The SH2 and SH3 domain-containing proteins GRB 2 links receptor tyrosine kinases to ras signaling. Cell 70:431-42
177. Case RD, Piccione E, Wolf G, Benett AM, Lechleider RJ, et al. 1994. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor β-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides. J. Biol. Chem. 269:10467-74
178. Lechleider RJ, Freeman RM, Neel BG. 1993. Tyrosyl phosphorylation and growth factor receptor association of the human corkscrew homologue, SHPTP2. J Biol. Chem. 268:13434-38
179. Lechleider RJ, Sugimoto S, Bennett AM, Kashishian AS, Cooper JA, et al. 1993. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor B. J. Biol. Chem. 268:21478-81
180. Freeman RM, Plutzky J, Neel BG. 1992. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc. Natl. Acad. Sci. USA 89:11239-43
181. Xiao S, Roses DW, Sasaoka T, Maegawa H, Burke H Jr, et al. 1994. J. Biol. Chem. 269:21244-48
182. Hausdorff SF, Bennett AM, Neel BG, Birnbaum MJ. 1995. Different signaling roles of SHPTP2 in insulin-induced GLUT1 expression and GLUT4 translocation. J. Biol. Chem. 270:12965-68
183. Noguchi T, Matozaki T, Horita K, Fujioka Y, Kasuga M. 1994. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated ras activation. Mol. Cell. Biol. 14:6674-82
184. Milarski KL, Saltiel AR. 1995. Expression of catalytically inactive syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem. 269:21239-43
185. Yamauchi K, Milarski KL, Saltiel AR, Pessin JE. 1995. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc. Natl. Acad. Sci. USA 92:664-68
186. ras-GTP formation. J. Biol. Chem. 269:33116-22
187. Yonezawa K, Ando A, Kaburagi Y, Yamamotohonda R, Kitamura T, et al. 1994. Signal transduction pathways from insulin receptor to ras-analysis by mutant insulin receptors. J. Biol. Chem. 269:4634-40
188. Sasaoka T, Draznin B, Leitner JW, Langlois WJ, Olefsky JM. 1994. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras formation. J. Biol. Chem. 269: 10734-38
189. Staubs PA, Reichart DR, Saltiel AR, Milarski KL, Maegawa H, et al. 1994. Localization of the insulin receptor binding sites for the SH2 domain proteins p85, syp, and GAP. J. Biol. Chem. 269:27186-92
190. 538 and the catalytic activity of PTP1C, a protein tyrosine phosphatase with Src homology-2 domains. J. Biol. Chem. 269:12220-28
191. Zhou-Li F, D'Ambrosio C, Li S, Surmacz E, Baserga R. 1995. Association of insulin receptor substrate 1 with simian virus 40 large T antigen. Mol. Cell. BioL 15:4232-39
192. Shimizu K, Kuroda S, Yamamori B, Matsuda S, Kaibuchi K, et al. 1994. Synergistic activation by Ras and 14-3-3 protein of a mitogen-activated protein kinase kinase kinase named Ras-dependent extracellular signal-regulated kinase kinase stimulator. J. Biol. Chem. 269:22917-20
193. Freed E, Symons M, Macdonald SG, McCormick F, Ruggieri R. 1994. Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science 265:1713-16
194. Irie K, Gotoh Y, Yashar BM, Errede B, Nishida E, Matsumoto K. 1994. Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase. Science 265:1716-19
195. Fu H, Xia K, Pallas DC, Cui C, Conroy K, et al. 1994. Interaction of the protein kinase Raf-1 with 14-3-3 proteins [see comments]. Science 266:126-29
196. Fanti WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, et al. 1994. Activation of Raf-1 by 14-3-3 proteins. Nature 371:612-14
197. Tanji M, Horwitz R, Rosenfeld G, Waymire JC. 1994. Activation of protein kinase C by purified bovine brain 14-3-3: comparison with tyrosine hydroxylase activation. J. Neurochem. 63: 1908-16
198. Pallas DC, Fu H, Haehnel LC, Weller W, Collier RJ, Roberts TM. 1994. Association of polyomavirus middle tumor antigen with 14-3-3 proteins. Science 265:535-37
199. Du X, Harris SJ, Tetaz TJ, Ginsberg MH, Berndt MC. 1994. Association of a phospholipase A2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex. J. Biol. Chem. 269:18287-90
200. Chen F, Wagner PD. 1994. 14-3-3 proteins bind to histone and affect both histone phosphorylation and dephosphorylation. FEBS Lett. 347:128-32
201. Robinson K, Jones D, Patel Y, Martin H, Madrazo J, et al. 1994. Mechanism of inhibition of protein kinase C by 14-3-3 isoforms. 14-3-3 isoforms do not have phospholipase A2 activity. Biochem. J. 299:853-61
202. Furukawa Y, Ikuta N, Omata S, Yamauchi T, Isobe T, Ichimura T. 1993. Demonstration of the phosphorylation-dependent interaction of tryptophan hydroxylase with the 14-3-3 protein. Biochem. Biophys. Res. Commun. 194: 144-49
203. Conklin DS, Galaktionov K, Beach D. 1995. 14-3-3 proteins associate with cdc25 phosphatase. Proc. Natl. Acad. Sci. USA 92:7892-96
204. Ford JC, Al-Khodairy F, Fotou E, Sheldrick KS, Griffiths DJ, Carr AM. 1994. 14-3-3 protein homologs required for the DNA damage checkpoint in fission yeast. Science 265:533-35
205. Xiao B, Smerdon SJ, Jones DH, Dodson GG, Soneji Y, et al. 1995. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 376:188-91
206. Liu D, Bienkowska J, Petosa C, Collier RJ, Fu H, Liddington R. 1995. Crystal structure of the zeta isoform of the 14-3-3 protein. Nature 376:191-94
207. Vuori K, Ruoslahti E. 1994. Association of insulin receptor substrate-1 with integrins. Science 266:1576-78
208. Clark EA, Brugge JS. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233-39
209. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B III, et al. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-90
210. Tamemoto H, Kadowaki T, Tobe K, Tobe K, Yagi T, Sakura H, et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-86
211. Yamauchi K, Pessin JE. 1994. Enhancement or inhibition of insulin signaling by insulin receptor substrate 1 is cell context dependent. Mol. Cell. Biol. 14: 4427-34
212. Rose DW, Saltiel AR, Majumdar M, Decker SJ, Olefsky JM. 1994. Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction. Proc. Natl. Acad. Sci. USA 91:797-801
213. Waters SB, Yamauchi K, Pessin JE. 1993. Functional expression of insulin receptor substrate-1 is required for insulin-stimulated mitogenic signaling. J. Biol. Chem. 238:22231-34
214. Pessin JE, Bell GI. 1992. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu. Rev. Physiol. 54:911-30
215. Lienhard GE, Slot JW, James DE, Mueckler MM. 1992. How cells absorb glucose. Sci. Am. 266:86-91
216. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J. Biochem. 269:3568-73
217. Ridderstrale M, Tornqvist H. 1994. PI-3-tanase inhibitor wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 203: 306-10
218. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M. 1994. Essential role of phsophatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes-studies with a selective inhibitor wortmannin. J. Biol. Chem. 269:3568-73
219. Fingar DC, Birnbaum MJ. 1994. A role for raf-1 in the divergent signaling pathways mediating insulin-stimulated glucose transport. J. Biol. Chem. 269: 10127-32
220. Olson AL, Liu ML, Moye-Rowley WS, Buse JB, Bell GI, Pessin JE. 1993. Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice. J. Biol. Chem. 268:9839-46
221. Hausdorff SF, Frangioni JV, Birnbaum MJ. 1994. Role of p21ras in insulin-stimulated glucose transport in 3T3-L1 adipocytes. J. Biol. Chem. 269:21391-94
222. Proud CG. 1994. Turned on by insulin. Nature 371:747-48
223. O'Brien C. 1994. Missing link in insulin's path to protein production. Science 266:542-43
224. Hu C, Pang S, Kong X, Velleca M, Lawrence JC. 1994. Molecular cloning and tissue disuibution of PHAS-I, an intracellular target for insulin and growth factors. Proc. Natl. Acad. Sci. USA 91:3730-34
225. Pause A, Belsham GJ, Gingras A, Donze O, Lin T, et al. 1994. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371:762-67
226. Lin TA, Kong XM, Haystead TAJ, Pause A, Belsham G, et al. 1994. PHAS-1 as a link, between mitogen-activated protein kinase and translation initiation. Science 266:653-56
227. Graves LM, Bornfeldt KE, Argast GM, Krebs EG, Kong X, et al. 1995. cAMP-and rapamycin-sensitjve regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-1 in aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA 92 7222-26
228. Lin TA, Kong X, Saltiel AR, Blackshear PJ, Lawrence JC Jr. 1995. Control of PHAS-1 by insulin in 3T3-L1 adipocytes. J. Biol. Chem. 270:18531-38
229. Deleted in proof
230. Tanti JF, Gremeaux T, Van Obberghen E, Le Marchand-Brustel Y. 1994. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J. Biol. Chem. 269: 6051-57
231. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. 1994. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest. 94:1543-49
232. Hotamisligil GS, Shargill NS, Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91
233. DeGroot LJ, ed. 1995. Endocrinology. Philadelphia: Saunders. 3rd ed.
234. Moller DE, ed. 1993. Insulin Resistance. New York: Wiley